CELLs--GE may or may not be involved. My understanding is that the surgical procedure should be as or less complicated than Laser surgery --which blossomed quickly and is now very common. Lanza and company have developed pre-loaded syringes to deliver the stem cells, simplifying matters greatly. Producing the cells and syringes is where GE stands a good chance of playing a role. I do not believe GE has the same resources at this time in terms of pharma reps, relationships with drs/hospitals or credibility as a J&J or Roche or other big pharmas. A GE may want a bigger role but I believe ACTC's interests are served better by having GE manufacture --something they do well--and having a J&J or Roche take care of the rest. All imho
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.